docetaxel anhydrous has been researched along with Cancer of Colon in 51 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 10 (19.61) | 18.2507 |
2000's | 20 (39.22) | 29.6817 |
2010's | 12 (23.53) | 24.3611 |
2020's | 9 (17.65) | 2.80 |
Authors | Studies |
---|---|
Dong, Z; Gao, Q; Guo, Y; Zhang, C; Zhang, L | 1 |
Gao, J; Li, H; Wang, Y; Wu, X; Zhao, J | 1 |
Mahmoudi, A; Malaekeh-Nikouei, B; Moosavian, SA; Shakib, Z | 1 |
Camps, MGM; Cruz, LJ; Da Silva, CG; Gu, Z; Hao, Y; Liu, Q; Ossendorp, F; Schomann, T; van der Maaden, K | 1 |
Abdel Monaim, SAH; Abdulmalek, SA; Albericio, F; Bahey-El-Din, M; Bekhit, AA; Elkhodairy, KA; Elmorshedy, YM; Elzoghby, AO; Ghareeb, DA; Khattab, SN; Sallam, MA; Teleb, M | 1 |
Castro, MG; Li, D; Moon, JJ; Scheetz, LM; Schwendeman, A; Yu, M | 1 |
Jiang, Z; Liu, J; Shu, M; Su, M; Xie, J; Zeng, Q | 1 |
Duan, J; Li, X; Yang, XD; Yu, Z | 1 |
Chiu, HI; Lim, V | 1 |
Cervantes, A; Moreno Vera, S; Peeters, M; Taieb, J | 1 |
Lee, ES; Lee, JM; Oh, KT; Park, H | 1 |
Beijnen, JH; Buil, L; Hoogendijk, L; Lin, F; van Tellingen, O | 1 |
Jayakumar, R; Lakshmanan, VK; Maya, S; Menon, D; Sarmento, B | 1 |
Barjat, H; Ehrlichmann, W; Honndorf, VS; Pichler, BJ; Quintanilla-Martinez, L; Ricketts, SA; Schmidt, H; Wehrl, HF; Wiehr, S | 1 |
Kostopoulos, A; Koutsilieris, M; Papageorgiou, E; Sivolapenko, G | 1 |
Fujii, Y; Fujita, H; Fujita, J; Funaki, H; Kaida, D; Kinami, S; Kosaka, T; Miura, S; Morioka, E; Nakano, Y; Noguchi, M; Ohonishi, T; Ohono, Y; Sakata, N; Tomita, Y; Ueda, N | 1 |
Deng, J; Fan, R; Gao, X; Guo, G; Li, X; Tong, A; You, C; Zhang, X; Zheng, Y; Zhou, L | 1 |
Corcos, L; Durand, S; El Khoury, F; Le Jossic-Corcos, C; Simon, B | 1 |
Bijnsdorp, IV; Fukushima, M; Gokoel, S; Kruyt, FA; Peters, GJ | 1 |
Gennatas, C; Gennatas, S; Michalaki, V | 1 |
Choi, SS; Han, SB; Hong, JT; Kim, SM; Kim, Y; Lee, SY; Moon, DC; Oh, KW; Yuk, DY | 1 |
Ban, JO; Han, SB; Hong, JT; Hwang, BY; Jeong, HS; Lee, HS; Moon, DC; Song, S; Yoon, DY | 1 |
Cho, JS; Han, SB; Hong, JT; Jung, JK; Lee, SY; Lee, YM; Moon, DC; Oh, KW; Yoo, HS; Yuk, DY | 1 |
Fujiwara, H; Ichikawa, D; Kubota, T; Matsumoto, K; Matsumura, A; Murayama, Y; Nakamura, T; Ochiai, T; Okamoto, K; Otsuji, E; Taiyoh, H | 1 |
Astruc, D; François, A; Laroche, A; Pinaud, N; Robert, J; Ruiz, J; Salmon, L | 1 |
Jiang, XQ; Li, RT; Liu, BR; Liu, Q; Qian, HQ; Qian, XP; Wu, W; Yang, M; Yu, LX; Zhu, ZS | 1 |
Krüger, I; Lindenfelser, R; Scherwitz, P | 1 |
Mayor, S | 1 |
Sawabu, N | 1 |
Baba, E; Katano, M; Matsunaga, H; Morisaki, T; Nakahara, C; Nakamura, K; Noshiro, H; Tanaka, M; Wada, M; Yamanaka, N | 1 |
Dunne, AL; Hirst, DG; Mothersill, C; Robson, T; Wilson, GD | 1 |
Blagosklonny, MV; Darzynkiewicz, Z; Demidenko, ZN; Halicka, D; Kunicki, J; McCubrey, JA | 1 |
Liu, H; Lu, HL; Song, CC; Wang, QW; Xu, CG | 1 |
Chen, DD; Huang, T; Lian, YJ | 1 |
Becerra, CR; Frenkel, EP; Fu, YC; Guo, J; Tripathy, D; Verma, UN; Zhou, AW | 1 |
Golemis, EA; Khazak, V; Menon, S; Skobeleva, N; Weber, L | 1 |
Chang, SY; Chang, WS; Kang, CY; Kim, YJ; Kim, YS; Ko, HJ; Ko, SY; Sakaguchi, S | 1 |
Bijman, MN; Boven, E; Hermelink, CA; Janmaat, ML; Laan, AC; Peters, GJ; van Berkel, MP | 1 |
Carstens, MG; Crommelin, DJ; de Jong, PH; de Leede, LG; Hennink, WE; Kemmink, J; van Nostrum, CF; Verrijk, R | 1 |
Bissery, MC; Dykes, DJ; Harrison, SD; Waud, WR | 1 |
Braguer, D; Briand, C; Carles, G; Garcia, P | 1 |
Taguchi, T | 1 |
Karantanis, E; Morris, DL; Nicholson, S | 1 |
Bissery, MC; Lavelle, F; Vrignaud, P | 1 |
Bernacki, RJ; Ojima, I; Sharma, A; Straubinger, RM | 1 |
Valero, V | 1 |
Fukase, Y; Ishikawa, T; Ishitsuka, H; Nishida, M; Sawada, N; Yoshikubo, T | 1 |
Braguer, D; Briand, C; Carles, G; Sabeur, G | 1 |
Holton, RA; Wang, HJ; Yang, LX | 1 |
Donaldson, KL; Mixan, BJ; Siegall, CB; Trail, PA; Wahl, AF | 1 |
Bissery, MC; Guénard, D; Guéritte-Voegelein, F; Lavelle, F | 1 |
3 review(s) available for docetaxel anhydrous and Cancer of Colon
Article | Year |
---|---|
Trifluridine/tipiracil: an emerging strategy for the management of gastrointestinal cancers.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Clinical Trials as Topic; Colonic Neoplasms; Docetaxel; Drug Combinations; Fluorouracil; Gastrointestinal Neoplasms; Humans; Immunotherapy; Indoles; Irinotecan; Organoplatinum Compounds; Oxaliplatin; Pyrrolidines; Quality of Life; Taxoids; Thymine; Trifluridine; Uracil | 2018 |
The role of capecitabine in the management of tumors of the digestive system.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Camptothecin; Capecitabine; Chemotherapy, Adjuvant; Cholangiocarcinoma; Colonic Neoplasms; Deoxycytidine; Digestive System Neoplasms; Docetaxel; Esophageal Neoplasms; Fluorouracil; Gallbladder Neoplasms; Humans; Irinotecan; Liver Neoplasms; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms; Rectal Neoplasms; Stomach Neoplasms; Taxoids; Treatment Outcome; Vascular Endothelial Growth Factor A | 2009 |
[Recent advances in chemotherapy for digestive cancers with special references to gastric and colonic cancers].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Colonic Neoplasms; Docetaxel; Drug Administration Schedule; Drug Combinations; Drug Delivery Systems; Fluorouracil; Humans; Irinotecan; Oxonic Acid; Paclitaxel; Pyridines; Stomach Neoplasms; Taxoids; Tegafur | 2003 |
2 trial(s) available for docetaxel anhydrous and Cancer of Colon
Article | Year |
---|---|
[An early phase II clinical study of RP56976 (docetaxel) in patients with cancer of the gastrointestinal tract].
Topics: Adenocarcinoma; Adult; Aged; Alopecia; Anorexia; Antineoplastic Agents, Phytogenic; Colonic Neoplasms; Docetaxel; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Neutropenia; Paclitaxel; Pancreatic Neoplasms; Stomach Neoplasms; Taxoids | 1994 |
Combination docetaxel/cyclophosphamide in patients with advanced solid tumors.
Topics: Adenocarcinoma; Adult; Aged; Antiemetics; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials, Phase II as Topic; Colonic Neoplasms; Cyclophosphamide; Dexamethasone; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fever; Granulocyte Colony-Stimulating Factor; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Middle Aged; Neoplasms; Neutropenia; Paclitaxel; Premedication; Remission Induction; Sarcoma; Taxoids | 1997 |
46 other study(ies) available for docetaxel anhydrous and Cancer of Colon
Article | Year |
---|---|
Effect and Prognosis Factors of Combining Laparoscopic Radical Resection of Colon Adenocarcinoma with Docetaxel Therapy in Treating Middle and Advanced Colon Adenocarcinoma.
Topics: Adenocarcinoma; Biomarkers, Tumor; Colonic Neoplasms; Docetaxel; Humans; Laparoscopy; Retrospective Studies | 2022 |
miR-194-3p represses the docetaxel resistance in colon cancer by targeting KLK10.
Topics: Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Docetaxel; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Kallikreins; MicroRNAs | 2022 |
PEGylated solid lipid nanoparticles functionalized by aptamer for targeted delivery of docetaxel in mice bearing C26 tumor.
Topics: Animals; Antineoplastic Agents; Carcinoma; Cell Line, Tumor; CHO Cells; Colonic Neoplasms; Cricetinae; Cricetulus; Docetaxel; Drug Carriers; Drug Delivery Systems; Liposomes; Mice; Mice, Inbred BALB C; Nanoparticles; Polyethylene Glycols | 2022 |
Effective combination of liposome-targeted chemotherapy and PD-L1 blockade of murine colon cancer.
Topics: Animals; Cell Line, Tumor; Colonic Neoplasms; Docetaxel; Liposomes; Mice; Pemetrexed; Tissue Distribution | 2023 |
Engineered Microencapsulated Lactoferrin Nanoconjugates for Oral Targeted Treatment of Colon Cancer.
Topics: Animals; Antineoplastic Agents; Colonic Neoplasms; Docetaxel; Drug Carriers; Drug Delivery Systems; Lactoferrin; Nanoconjugates; Nanoparticles; Rats | 2023 |
Synthetic HDL Nanoparticles Delivering Docetaxel and CpG for Chemoimmunotherapy of Colon Adenocarcinoma.
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Colonic Neoplasms; Docetaxel; Female; Immunotherapy; Lipoproteins, HDL; Mice; Mice, Inbred C57BL; Nanoparticles; Oligodeoxyribonucleotides; Toll-Like Receptor 9 | 2020 |
Enzymatic synthesis of PEGylated lactide-diester-diol copolyesters for highly efficient targeted anticancer drug delivery.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Dioxanes; Docetaxel; Drug Carriers; Drug Compounding; Female; Folic Acid; Mice; Nanoparticles; Particle Size; Polyesters; Polyethylene Glycols; Xenograft Model Antitumor Assays | 2020 |
Targeted Treatment of Colon Cancer with Aptamer-Guided Albumin Nanoparticles Loaded with Docetaxel.
Topics: Animals; Antineoplastic Agents; Aptamers, Nucleotide; Cell Line, Tumor; CHO Cells; Colonic Neoplasms; Cricetulus; Docetaxel; Drug Carriers; Drug Delivery Systems; Drug Liberation; Female; Mice, Inbred BALB C; Nanoparticles; Neoplasms, Experimental; Oligodeoxyribonucleotides; Serum Albumin, Bovine | 2020 |
Wheat Germ Agglutinin-Conjugated Disulfide Cross-Linked Alginate Nanoparticles as a Docetaxel Carrier for Colon Cancer Therapy.
Topics: Alginates; Animals; Antineoplastic Agents; Colonic Neoplasms; Disulfides; Docetaxel; Drug Carriers; Dynamic Light Scattering; HT29 Cells; Humans; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Mice; Microscopy, Electron, Scanning; Nanoparticles; Wheat Germ Agglutinins | 2021 |
pH-Responsive hyaluronated liposomes for docetaxel delivery.
Topics: Animals; Antineoplastic Agents; Chemistry, Pharmaceutical; Colonic Neoplasms; Docetaxel; Drug Carriers; Drug Delivery Systems; Female; Glycine max; HCT116 Cells; Humans; Hyaluronic Acid; Hydrogen-Ion Concentration; KB Cells; Liposomes; Mice; Mice, Inbred BALB C; Phosphatidylcholines; Taxoids | 2018 |
Sildenafil is not a useful modulator of ABCB1 and ABCG2 mediated drug resistance in vivo.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Brain; Cell Line, Tumor; Cell Proliferation; Chromatography, High Pressure Liquid; Colonic Neoplasms; Docetaxel; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Mice; Mice, Inbred BALB C; Mice, Knockout; Piperazines; Purines; Sildenafil Citrate; Sulfones; Taxoids; Topoisomerase I Inhibitors; Topotecan; Tumor Burden; Vasodilator Agents | 2013 |
Actively targeted cetuximab conjugated gamma-poly(glutamic acid)-docetaxel nanomedicines for epidermal growth factor receptor over expressing colon cancer cells.
Topics: Animals; Annexins; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzimidazoles; Carbocyanines; Cell Cycle; Cell Death; Cetuximab; Colonic Neoplasms; Docetaxel; Drug Carriers; ErbB Receptors; Hemolysis; HT29 Cells; Humans; Mice; Nanomedicine; Nanoparticles; Polyglutamic Acid; Taxoids; Tissue Distribution | 2014 |
Quantitative correlation at the molecular level of tumor response to docetaxel by multimodal diffusion-weighted magnetic resonance imaging and [¹⁸F]FDG/[¹⁸F]FLT positron emission tomography.
Topics: Animals; Antineoplastic Agents; Colonic Neoplasms; Dideoxynucleosides; Diffusion Magnetic Resonance Imaging; Docetaxel; Female; Fluorodeoxyglucose F18; HCT116 Cells; Humans; Mice; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Taxoids; Treatment Outcome; Xenograft Model Antitumor Assays | 2014 |
PCK3145 inhibits proliferation and induces apoptosis in breast and colon cancer cells.
Topics: Apoptosis; Breast Neoplasms; Cell Proliferation; Colonic Neoplasms; Docetaxel; Female; HT29 Cells; Humans; MAP Kinase Signaling System; MCF-7 Cells; Organoplatinum Compounds; Oxaliplatin; Peptide Fragments; Prostatic Secretory Proteins; Receptors, Laminin; Taxoids | 2015 |
[A Successful Case of Treatment of Colonic Metastasis and Peritoneal Recurrence of Type 4 Gastric Cancer by Using Colectomy and Chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colectomy; Colonic Neoplasms; Docetaxel; Drug Combinations; Fatal Outcome; Female; Humans; Oxonic Acid; Recurrence; Stomach Neoplasms; Taxoids; Tegafur | 2015 |
Dual Drug Loaded Biodegradable Nanofibrous Microsphere for Improving Anti-Colon Cancer Activity.
Topics: Abdominal Neoplasms; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Colonic Neoplasms; Curcumin; Docetaxel; Drug Carriers; Drug Screening Assays, Antitumor; Flow Cytometry; Hemolysis; Humans; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred BALB C; Microspheres; Molecular Weight; Nanofibers; Nanoparticles; Neoplasm Metastasis; Poloxamer; Polymers; Spectroscopy, Fourier Transform Infrared; Taxoids; Thermogravimetry; X-Ray Diffraction | 2016 |
Acquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cells.
Topics: Antigens, CD; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Cell Adhesion Molecules, Neuronal; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Dipeptidyl Peptidase 4; Docetaxel; Drug Resistance, Neoplasm; Fetal Proteins; HCT116 Cells; HT29 Cells; Humans; Integrin beta1; Neoplastic Stem Cells; Organoplatinum Compounds; Oxaliplatin; Phenotype; Receptor, EphB2; Taxoids | 2016 |
Synergistic interaction between trifluorothymidine and docetaxel is sequence dependent.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Colonic Neoplasms; Docetaxel; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Fluorescent Antibody Technique; Humans; Taxoids; Trifluridine | 2008 |
Inhibition of NF-kappaB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Cell Cycle Proteins; Cell Proliferation; Cisplatin; Colonic Neoplasms; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Ginsenosides; HCT116 Cells; Humans; Inhibitory Concentration 50; NF-kappa B; Paclitaxel; Taxoids | 2009 |
Thiacremonone augments chemotherapeutic agent-induced growth inhibition in human colon cancer cells through inactivation of nuclear factor-{kappa}B.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Docetaxel; Drug Administration Schedule; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Taxoids; Thiophenes; Xenograft Model Antitumor Assays | 2009 |
Obovatol enhances docetaxel-induced prostate and colon cancer cell death through inactivation of nuclear transcription factor-kappaB.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Biphenyl Compounds; Cell Death; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Colonic Neoplasms; Docetaxel; Drug Synergism; Fluorescent Dyes; HCT116 Cells; Humans; In Situ Nick-End Labeling; Indoles; Inhibitory Concentration 50; Magnolia; Male; Molecular Structure; NF-kappa B; Phenyl Ethers; Plant Leaves; Prostatic Neoplasms; Taxoids | 2009 |
NK4 gene expression enhances 5-fluorouracil-induced apoptosis of murine colon cancer cells.
Topics: Animals; Apoptosis; Cisplatin; Colonic Neoplasms; Combined Modality Therapy; Cricetinae; Cricetulus; Docetaxel; Female; Fluorouracil; Gene Expression; Genetic Therapy; Hepatocyte Growth Factor; Mice; Mice, Inbred BALB C; Proto-Oncogene Proteins c-met; RNA, Messenger; Taxoids; Thymidylate Synthase | 2011 |
Encapsulation of docetaxel into PEGylated gold nanoparticles for vectorization to cancer cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Colonic Neoplasms; Docetaxel; Drug Carriers; Female; Gold; Humans; Magnetic Resonance Spectroscopy; Metal Nanoparticles; Polyethylene Glycols; Solubility; Spectrophotometry, Ultraviolet; Taxoids | 2011 |
Gelatinase-stimuli strategy enhances the tumor delivery and therapeutic efficacy of docetaxel-loaded poly(ethylene glycol)-poly(ɛ-caprolactone) nanoparticles.
Topics: Absorbable Implants; Animals; Antineoplastic Agents; Biocompatible Materials; Carcinoma, Lewis Lung; Colonic Neoplasms; Docetaxel; Drug Carriers; Drug Delivery Systems; Gelatinases; Humans; Injections, Intravenous; Liver Neoplasms, Experimental; Lung Neoplasms; Male; Mice; Mice, Inbred ICR; Multimodal Imaging; Nanoparticles; Particle Size; Positron-Emission Tomography; Random Allocation; Taxoids; Tissue Distribution; Tomography, X-Ray Computed; Tumor Cells, Cultured | 2012 |
[Localization of primary small cell carcinoma with liver metastasis: a rare combination of colonic adenocarcinoma and undifferentiated small cell carcinoma].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Colectomy; Colon; Colonic Neoplasms; Docetaxel; Doxorubicin; Etoposide; Female; Humans; Immunohistochemistry; Liver; Liver Neoplasms; Neoplasms, Multiple Primary; Neoplasms, Unknown Primary; Paclitaxel; Taxoids; Time Factors; Vincristine | 2002 |
NICE recommends new treatment for breast and bowel cancer.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Colonic Neoplasms; Deoxycytidine; Docetaxel; Female; Fluorouracil; Humans; Paclitaxel; Practice Guidelines as Topic; Taxoids; Tegafur; Uracil | 2003 |
Cyclosporin-A enhances docetaxel-induced apoptosis through inhibition of nuclear factor-kappaB activation in human gastric carcinoma cells.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Caspase Inhibitors; Caspases; Chromatography, High Pressure Liquid; Colonic Neoplasms; Cyclosporine; Docetaxel; Drug Combinations; Enzyme Inhibitors; Female; Humans; Mice; Mice, Inbred BALB C; NF-kappa B; Peritoneal Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Stomach Neoplasms; Taxoids; Tumor Cells, Cultured | 2003 |
Radiosensitization of colon cancer cell lines by docetaxel: mechanisms of action.
Topics: Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Docetaxel; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Humans; Radiation-Sensitizing Agents; Taxoids | 2004 |
Selective killing of adriamycin-resistant (G2 checkpoint-deficient and MRP1-expressing) cancer cells by docetaxel.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Docetaxel; Doxorubicin; Flavonoids; G2 Phase; HCT116 Cells; Hematopoietic Stem Cells; HL-60 Cells; Humans; MAP Kinase Kinase Kinases; Multidrug Resistance-Associated Proteins; Proto-Oncogene Proteins c-raf; Taxoids; Transfection | 2005 |
Radiosensitivity of human colon cancer cell enhanced by immunoliposomal docetaxel.
Topics: Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Docetaxel; Dose-Response Relationship, Radiation; Humans; Liposomes; Radiation-Sensitizing Agents; Taxoids | 2005 |
[Antisense RNA targeting survivin enhances the chemosensitivity of LOVO/Adr cells to taxotere].
Topics: Apoptosis; Cell Line, Tumor; Colonic Neoplasms; Docetaxel; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Microtubule-Associated Proteins; RNA, Antisense; RNA, Messenger; Taxoids; Transfection | 2005 |
Efficacy of sequential treatment of HCT116 colon cancer monolayers and xenografts with docetaxel, flavopiridol, and 5-fluorouracil.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Proliferation; Colonic Neoplasms; Docetaxel; Female; Flavonoids; Fluorouracil; HCT116 Cells; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Piperidines; Taxoids | 2006 |
In vitro and in vivo synergy of MCP compounds with mitogen-activated protein kinase pathway- and microtubule-targeting inhibitors.
Topics: 3T3 Cells; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Proliferation; Cell Transformation, Neoplastic; Colonic Neoplasms; Docetaxel; Drug Synergism; Enzyme Inhibitors; Humans; In Vitro Techniques; Lung Neoplasms; Male; Mice; Mice, Nude; Mice, SCID; Microtubules; Mitogen-Activated Protein Kinases; Paclitaxel; Proto-Oncogene Proteins c-raf; Proto-Oncogene Proteins p21(ras); Signal Transduction; Taxoids; Transcriptional Activation; Tumor Cells, Cultured; Vincristine; Xenograft Model Antitumor Assays | 2007 |
A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model.
Topics: Adenoviridae; Animals; Antigens, CD; Antigens, Differentiation; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Combined Modality Therapy; CTLA-4 Antigen; Cyclophosphamide; Dendritic Cells; Deoxycytidine; Docetaxel; Doxorubicin; Female; Flow Cytometry; Galactosylceramides; Gemcitabine; Genetic Vectors; Glucocorticoid-Induced TNFR-Related Protein; Humans; Immunization; Immunotherapy; Mice; Myeloid Cells; Peptide Fragments; Receptor, ErbB-2; Receptors, Nerve Growth Factor; Receptors, Tumor Necrosis Factor; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory; Taxoids; Transfection; Vaccines, DNA | 2007 |
Interaction between celecoxib and docetaxel or cisplatin in human cell lines of ovarian cancer and colon cancer is independent of COX-2 expression levels.
Topics: Antineoplastic Agents; Apoptosis; Celecoxib; Cell Division; Cell Line, Tumor; Cisplatin; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Cyclooxygenase 2; DNA Adducts; Docetaxel; Drug Interactions; Extracellular Signal-Regulated MAP Kinases; Female; G2 Phase; Humans; Ovarian Neoplasms; Pyrazoles; Sulfonamides; Taxoids | 2008 |
The effect of core composition in biodegradable oligomeric micelles as taxane formulations.
Topics: Animals; Chemistry, Pharmaceutical; Colonic Neoplasms; Docetaxel; Drug Stability; Magnetic Resonance Spectroscopy; Mice; Micelles; Paclitaxel; Particle Size; Taxoids | 2008 |
Response of human tumor xenografts in athymic nude mice to docetaxel (RP 56976, Taxotere).
Topics: Animals; Antineoplastic Agents, Phytogenic; Colonic Neoplasms; Docetaxel; Drugs, Investigational; Female; Humans; Lung Neoplasms; Mammary Neoplasms, Experimental; Melanoma; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Paclitaxel; Taxoids; Transplantation, Heterologous | 1995 |
[Effect of the association of antimitotic agents on cell lines of human adenocarcinoma].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carbamates; Colonic Neoplasms; Docetaxel; Humans; Paclitaxel; Pyrazines; Pyridines; Skin Neoplasms; Taxoids; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Vinblastine; Vinorelbine | 1994 |
Taxotere inhibits in-vitro growth of human colonic cancer cell lines.
Topics: Antineoplastic Agents, Phytogenic; Cell Cycle; Colonic Neoplasms; DNA, Neoplasm; Docetaxel; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Paclitaxel; Taxoids; Time Factors; Tumor Cells, Cultured | 1994 |
Preclinical profile of docetaxel (taxotere): efficacy as a single agent and in combination.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Colonic Neoplasms; Docetaxel; Female; Humans; Leukemia P388; Male; Mammary Neoplasms, Experimental; Melanoma, Experimental; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Paclitaxel; Taxoids | 1995 |
Antitumor efficacy of taxane liposomes on a human ovarian tumor xenograft in nude athymic mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Bridged-Ring Compounds; Carcinoma; Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Docetaxel; Drug Carriers; Female; Humans; Liposomes; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Paclitaxel; Taxoids | 1995 |
Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Docetaxel; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Induction; Female; Fluorouracil; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Paclitaxel; Taxoids; Thymidine Phosphorylase; Transplantation, Heterologous; Tumor Necrosis Factor-alpha; Up-Regulation | 1998 |
The effect of combining antitubulin agents on differentiated and undifferentiated human colon cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Cell Differentiation; Cell Division; Cell Survival; Colonic Neoplasms; Docetaxel; Dose-Response Relationship, Drug; Drug Synergism; Humans; Paclitaxel; Taxoids; Time Factors; Tubulin; Tumor Cells, Cultured; Vinblastine; Vinorelbine | 1998 |
In vitro efficacy of a novel chemoradiopotentiator--taxoltere metro.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Hypoxia; Cell Survival; CHO Cells; Colonic Neoplasms; Cricetinae; Docetaxel; Drug Resistance, Neoplasm; Humans; Paclitaxel; Radiation-Sensitizing Agents; Taxoids; Tumor Cells, Cultured | 2000 |
Selective tumor sensitization to taxanes with the mAb-drug conjugate cBR96-doxorubicin.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Cycle; Colonic Neoplasms; Docetaxel; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Immunotoxins; Inhibitory Concentration 50; Lewis Blood Group Antigens; Lung Neoplasms; Mice; Mice, Nude; Paclitaxel; Taxoids; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2001 |
Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue.
Topics: Adenocarcinoma; Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Intraductal, Noninfiltrating; Colonic Neoplasms; Docetaxel; Female; Leukemia, Experimental; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Transplantation; Neoplasms, Experimental; Osteosarcoma; Paclitaxel; Pancreatic Neoplasms; Sarcoma, Experimental; Taxoids | 1991 |